Cite
HARVARD Citation
Dorta-Estremera, S. et al. (2019). Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer. Journal for immunotherapy of cancer. 7 (1), p. . [Online].